Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for 2019 (655 publications)

no pagination
Song S, Jiang J, Zhao L, Wang Q, Lu W, Zheng C, Zhang J, Ma H, Tian S, Zheng J, Luo L, Li Y, Yang ZJ, Zhang X. Structural optimization on a virtual screening hit of smoothened receptor. European journal of medicinal chemistry. 2019 Jun 15;172:1-15.
Gockley A, Melamed A, Cronin A, Bookman MA, Burger RA, Cristae MC, Griggs JJ, Mantia-Smaldone G, Matulonis UA, Meyer LA, Niland J, O'Malley DM, Wright AA. Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer. American journal of obstetrics and gynecology. 2019 Jun 14;.
Cote JM, Kuo YM, Henry RA, Scherman H, Krzizike DD, Andrews AJ. Two factor authentication: Asf1 mediates crosstalk between H3 K14 and K56 acetylation. Nucleic acids research. 2019 Jun 13;47(14):7380-91.   PMCID: PMC6698667
Rimm DL, Han G, Taube JM, Yi ES, Bridge JA, Flieder DB, Homer R, Roden AC, Hirsch FR, Wistuba, Pusztai L. Reanalysis of the NCCN PD-L1 companion diagnostic assay study for lung cancer in the context of PD-L1 expression findings in triple-negative breast cancer. Breast Cancer Res. 2019 Jun 13;21(1):72.   PMCID: PMC6567382
Aggarwal C, Redman MW, Lara PN, Borghaei H, Hoffman P, Bradley JD, Newman AJ, Feldman MJ, Minichiello K, Miao J, Mack PC, Papadimitrakopoulou VA, Herbst RS, Kelly K, Gandara DR. Brief Report: SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously-treated Patients with Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study). J Thorac Oncol. 2019 Jun 10;.
Andres SF, Williams KN, Plesset JB, Headd JJ, Mizuno R, Chatterji P, Lento AA, Klein-Szanto AJ, Mick R, Hamilton KE, Rustgi AK. IMP1 3' UTR shortening enhances metastatic burden in colorectal cancer. Carcinogenesis. 2019 Jun 10;40(4):569-79.   PMCID: PMC6556707
Zhang Y, Wang WE, Zhang X, Li Y, Chen B, Liu C, Ai X, Zhang X, Tian Y, Zhang C, Tang M, Szeto C, Hua X, Xie M, Zeng C, Wu Y, Zhou L, Zhu W, Yu D, Houser SR, Chen X. Cardiomyocyte PKA Ablation Enhances Basal Contractility While Eliminates Cardiac beta-Adrenergic Response Without Adverse Effects on the Heart. Circulation research. 2019 Jun 07;124(12):1760-77.
Li P, Jahnke J, Pettit AR, Wong YN, Doshi JA. Comparative Survival Associated With Use of Targeted vs Nontargeted Therapy in Medicare Patients With Metastatic Renal Cell Carcinoma. JAMA network open. 2019 Jun 05;2(6):e195806.   PMCID: PMC6575152
Barta SK, Zain J, MacFarlane AW, Smith SM, Ruan J, Fung HC, Tan CR, Yang Y, Alpaugh RK, Dulaimi E, Ross EA, Campbell KS, Khan N, Siddharta R, Fowler NH, Fisher RI, Oki Y. Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma. Clinical lymphoma, myeloma & leukemia. 2019 Jun;19(6):356-364 e3.
Chatterji P, Williams PA, Whelan KA, Samper FC, Andres SF, Simon LA, Parham LR, Mizuno R, Lundsmith ET, Lee DS, Liang S, Wijeratne HS, Marti S, Chau L, Giroux V, Wilkins BJ, Wu GD, Shah P, Tartaglia GG, Hamilton KE. Posttranscriptional regulation of colonic epithelial repair by RNA binding protein IMP1/IGF2BP1. EMBO reports. 2019 Jun;20(6).   PMCID: PMC6549032
Daher SS, Jin X, Patel J, Freundlich JS, Buttaro B, Andrade RB. Synthesis and biological evaluation of solithromycin analogs against multidrug resistant pathogens. Bioorganic & medicinal chemistry letters. 2019 Jun;29(11):1386-9.   PMCID: PMC6487207
Davis SM, Lepore SJ, Dumenci L. Psychometric properties and correlates of a brief scale measuring the psychological construct mattering to others in a sample of women recovering from breast cancer. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2019 Jun;28(6):1605-14.   PMCID: PMC6525027
DuBay DA, Ivankova NV, Herbey I, Redden DT, Holt C, Siminoff L, Fouad MN, Morinelli TA, Martin MY. An African American Perspective on Familial Notification of Becoming a Registered Organ Donor. Progress in transplantation (Aliso Viejo, Calif). 2019 Jun;29(2):164-72.
Dumenci L, Perera RA, Keefe FJ, Ang DC, Slover J, Jensen MP, Riddle DL. Model-based pain and function outcome trajectory types for patients undergoing knee arthroplasty: a secondary analysis from a randomized clinical trial. Osteoarthritis and cartilage. 2019 Jun;27(6):878-84.   PMCID: PMC6536318
Fang CY, Lee M, Feng Z, Tan Y, Levine F, Nguyen C, Ma GX. Community-Based Cervical Cancer Education: Changes in Knowledge and Beliefs Among Vietnamese American Women. J Community Health. 2019 Jun;44(3):525-33.   PMCID: PMC6529234
Garcia-Manero G, Roboz G, Walsh K, Kantarjian H, Ritchie E, Kropf P, O'Connell C, Tibes R, Lunin S, Rosenblat T, Yee K, Stock W, Griffiths E, Mace J, Podoltsev N, Berdeja J, Jabbour E, Issa JJ, Hao Y, Keer HN, Azab M, Savona MR. Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial. The Lancet Haematology. 2019 Jun;6(6):e317-e327.
Halpern MT, Dodd SJ, Fang CY, Tan Y, Zhu L, Ogunwobi OO, Ma GX. EVALUATION OF A TRANSDISCIPLINARY CANCER RESEARCH TRAINING PROGRAM FOR UNDER-REPRESENTED MINORITY STUDENTS. Informing Science and IT Education Conference : proceedings and schedule Informing Science and IT Education Conference. 2019 Jun;2019:99-108.   PMCID: PMC6693898
Kestel J, von Mehren M. Honing in on Subtypes to Guide More Individualized Treatment of Soft Tissue Sarcoma. Oncology-New York. 2019 Jun;33(6):212-+.
Klein-Szanto AJ, Bassi DE. Keep recycling going: new approaches to reduce LDL-C. Biochemical pharmacology. 2019 Jun;164:336-41.
Lee JW, Parameswaran J, Sandoval-Schaefer T, Eoh KJ, Yang DH, Zhu F, Mehra R, Sharma R, Gaffney SG, Perry EB, Townsend JP, Serebriiskii IG, Golemis EA, Issaeva N, Yarbrough WG, Koo JS, Burtness BA. Combined Aurora kinase A (AURKA) and WEE1 inhibition demonstrates synergistic antitumor effect in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2019 Jun;25(11):3430-42.   PMCID: PMC6548643
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications for the year 2019


Last updated on Friday, December 06, 2019